Abstract

Introduction: The study used electronic prescription data to describe the status of glycemic control and prescribing in outpatients with type 2 diabetes at the central hospital of endocrinology. Subjects: Outpatients with type 2 diabetes who had health insurance and adhered to their follow-up visits from January to December 2019. Methods: Retrospective descriptive design with whole-sample sampling. Results: 96.5% of the patients had HbA1c tests at least 2 times per year: 46.9% of HbA1c tests resulted in <7%. Metformin and insulin were prescribed for about ~80% and 65% of patients, respectively. Combination regimens of insulin and 2 or more oral antihyperglycemic drugs accounted for about ~30% and a combination of 3 or more oral medications accounted for approximately ~20% of prescriptions. 53.2% of the regimens at HbAlc <7% were oral medications only, in single or combinations. More than 90% of regiment at HbA1c ≥ 8.5% had insulin only or insulin with oral medications. The prescription rates of SGLT2 inhibitors for diabetic patients with cardiovascular or chronic kidney diseases were 10-12%. Conclusions: About half of the studied patients had HbAlc <7%. About antihyperglycemic prescribing. metformin was used in most patients, and the regimen of insulin with 2 oral medications was the most popular. More than half of patients with HbAlc<7% were prescribed only oral medications while most patients with HbAlc≥ 8.5% were prescribed insulin. Low proportions of diabetic patients with cardiovascular disease or kidney disease were prescribed SGLT2 inhibitors.